ORMP
Price
$2.28
Change
-$0.04 (-1.72%)
Updated
Jan 17 closing price
Capitalization
91.91M
39 days until earnings call
TSHA
Price
$1.53
Change
-$0.05 (-3.16%)
Updated
Jan 17 closing price
Capitalization
313.56M
67 days until earnings call
Ad is loading...

ORMP vs TSHA

Header iconORMP vs TSHA Comparison
Open Charts ORMP vs TSHABanner chart's image
Oramed Pharmaceuticals
Price$2.28
Change-$0.04 (-1.72%)
Volume$137.56K
Capitalization91.91M
Taysha Gene Therapies
Price$1.53
Change-$0.05 (-3.16%)
Volume$1.92M
Capitalization313.56M
ORMP vs TSHA Comparison Chart
Loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORMP vs. TSHA commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORMP is a Hold and TSHA is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ORMP: $2.28 vs. TSHA: $1.53)
Brand notoriety: ORMP and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORMP: 80% vs. TSHA: 46%
Market capitalization -- ORMP: $91.91M vs. TSHA: $313.56M
ORMP [@Biotechnology] is valued at $91.91M. TSHA’s [@Biotechnology] market capitalization is $313.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORMP’s FA Score shows that 0 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • ORMP’s FA Score: 0 green, 5 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than TSHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORMP’s TA Score shows that 3 TA indicator(s) are bullish while TSHA’s TA Score has 4 bullish TA indicator(s).

  • ORMP’s TA Score: 3 bullish, 3 bearish.
  • TSHA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ORMP and TSHA are a good buy in the short-term.

Price Growth

ORMP (@Biotechnology) experienced а -4.60% price change this week, while TSHA (@Biotechnology) price change was -13.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

ORMP is expected to report earnings on May 28, 2025.

TSHA is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSHA($314M) has a higher market cap than ORMP($91.9M). ORMP has higher P/E ratio than TSHA: ORMP (20.73) vs TSHA (2.43). ORMP YTD gains are higher at: -5.785 vs. TSHA (-11.561). ORMP has higher annual earnings (EBITDA): 9.44M vs. TSHA (-20.67M). TSHA has more cash in the bank: 158M vs. ORMP (142M). ORMP has less debt than TSHA: ORMP (429K) vs TSHA (62.5M). TSHA has higher revenues than ORMP: TSHA (9.92M) vs ORMP (0).
ORMPTSHAORMP / TSHA
Capitalization91.9M314M29%
EBITDA9.44M-20.67M-46%
Gain YTD-5.785-11.56150%
P/E Ratio20.732.43853%
Revenue09.92M-
Total Cash142M158M90%
Total Debt429K62.5M1%
FUNDAMENTALS RATINGS
ORMP: Fundamental Ratings
ORMP
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
85
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
55
SEASONALITY SCORE
1..100
31

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ORMPTSHA
RSI
ODDS (%)
N/A
Bullish Trend 11 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 11 days ago
82%
Bearish Trend 11 days ago
90%
Momentum
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 11 days ago
85%
MACD
ODDS (%)
Bearish Trend 11 days ago
67%
Bullish Trend 11 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
81%
Bullish Trend 11 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
84%
Bearish Trend 11 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
82%
Bullish Trend 13 days ago
78%
Declines
ODDS (%)
Bearish Trend 11 days ago
84%
Bearish Trend 20 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
View a ticker or compare two or three
Ad is loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PYXS1.500.03
+2.04%
Pyxis Oncology
CTTAY6.860.09
+1.33%
Continental AG
NPSNY39.440.51
+1.32%
Naspers Ltd.
ILIKF0.25N/A
+1.00%
Ilika PLC.
SPGYF6.91-0.02
-0.36%
Whitecap Resources, Inc.

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with LOGC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then LOGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
-3.16%
LOGC - TSHA
45%
Loosely correlated
+1.93%
ORMP - TSHA
35%
Loosely correlated
-1.72%
ARWR - TSHA
35%
Loosely correlated
+2.84%
TRDA - TSHA
34%
Loosely correlated
+1.20%
AURA - TSHA
34%
Loosely correlated
+1.30%
More